Matrix metalloproteinases in coronary artery disease and myocardial infarction

Area of Science:

• Biomedical research
• Cardiovascular science
• Molecular biology

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of mortality.
• Atherosclerosis and myocardial infarction (MI) are major CVDs often linked to tissue remodeling.
• Matrix metalloproteinases (MMPs) regulate extracellular matrix and are implicated in CVD progression.

Purpose of the Study:

• To review MMP expression profiles in coronary artery and left ventricular tissues.
• To explore the association between MMP gene polymorphisms and CVD development/outcomes.
• To summarize current knowledge on MMPs in atherosclerosis and MI for potential therapeutic strategies.

Main Methods:

• Analysis of publicly available gene expression datasets (whole tissue to single-cell resolution).
• Review of human studies investigating MMP gene polymorphisms.
• Compilation of data from preclinical and clinical trials on MMP inhibition.

Main Results:

• MMP expression patterns in cardiovascular tissues provide insights into disease processes.
• MMP gene polymorphisms may influence susceptibility and outcomes in CVDs.
• Evidence suggests a role for MMPs in atherosclerosis and post-MI remodeling.

Conclusions:

• MMPs are critical players in the pathogenesis of atherosclerosis and myocardial infarction.
• Further research into MMPs and their polymorphisms could lead to novel diagnostic and therapeutic approaches for CVDs.
• Targeting MMPs pharmacologically shows potential but requires careful consideration based on diverse MMP functions.